Live Event Content · Dan Swarr, MD - 2024 Fetal Care Center Navigating Perinatal Care for Trisomy 13 & 18
Follow
Video26 min·Published Dec 2024

Dan Swarr, MD - 2024 Fetal Care Center Navigating Perinatal Care for Trisomy 13 & 18

With Dr. Daniel Swarr · hosted by Dr. Em Gootee
Try
Intelligent Search· scoped to trisomy 13 · not medical adviceSearch the whole library →
Only a few other public items share this expert — go deeper there →
What the experts said37 expert statements
Trisomy 13 and 18 were first described in back-to-back case reports in The Lancet in 1960.
ClinicalDaniel Swarr
In Weber et al.'s 1967 case series, about 28% of infants with trisomy 13/18 had died by 4 weeks of age and 87% had died by their first birthday.
EpidemiologicalDaniel Swarr
Literature from the 1980s and 1990s showed median survival for trisomy 18 ranging from 2.5 days to 2 weeks depending on the study.
EpidemiologicalDaniel Swarr
The conventional or historical approach to management of trisomy 13/18 was to offer only comfort care and withhold technological support such as mechanical ventilation or surgery.
ClinicalDaniel Swarr
A 2008 survey showed the conventional approach was a very commonly held view among neonatologists, but newer surveys suggest perspectives are changing.
EpidemiologicalDaniel Swarr
Medical interventions offered to infants with trisomy 13/18 have changed dramatically over the past 5-10 years in terms of delivery room resuscitation and NICU care including surgical care.
ClinicalDaniel Swarr
Quantitative futility means the medical intervention doesn't work at all; for example, mechanical ventilation will treat apnea, so calling it futile wouldn't apply in that situation.
ClinicalDaniel Swarr
The Ontario study (Nelson et al., JAMA 2016) was a retrospective cohort study spanning 1991-2012 with 174 trisomy 13 and 454 trisomy 18 infants, and the authors did not see a change in survival over time.
EpidemiologicalDaniel Swarr
In the Ontario study, the incidence was 6 per 100,000 live births for trisomy 13 and 8.8 per 100,000 live births for trisomy 18.
EpidemiologicalDaniel Swarr
Ontario survival curves show a steep drop-off in survival in the first month and especially the first week of life, but after that survival plateaus significantly, especially after 6 months of age.
EpidemiologicalDaniel Swarr
In the Ontario study, for trisomy 13, of infants alive at 30 days, 1-year survival was 47%, and of those alive at 6 months, 10-year survival was approximately 50%.
EpidemiologicalDaniel Swarr
In the Ontario study, for trisomy 18, of infants alive at 30 days, 1-year survival was 36%, and of those alive at 6 months, 10-year survival was 60%.
EpidemiologicalDaniel Swarr
In the Ontario study, 41 of 174 trisomy 13 infants received surgical procedures including major cardiac surgical procedures, GI procedures including G-tube, and tracheostomy placement.
EpidemiologicalDaniel Swarr
There is selection bias in which infants receive surgeries; many receiving surgeries are those who have already survived the first month or several months of life when mortality is highest.
ClinicalDaniel Swarr
The Cincinnati neonatology department covers all level 1 and level 2 nurseries in addition to NICUs, allowing capture of all live births in the region.
ClinicalDaniel Swarr
The Cincinnati study spanned January 1, 2012 to December 31, 2018 and included 125 fetuses or infants with trisomy 13 or 18.
EpidemiologicalDaniel Swarr
The Cincinnati live birth rate was 1 per 10,000 for trisomy 13 and 1.86 per 10,000 for trisomy 18, roughly double the rates in the Ontario study.
EpidemiologicalDaniel Swarr
In the Cincinnati study, spontaneous loss rates were about 6.5% for pregnancies prior to 20 weeks gestation and around 19% for pregnancies after 20 weeks gestation, totaling about 25%.
EpidemiologicalDaniel Swarr
In the Cincinnati study, the elective termination rate was around 17% and 58% of pregnancies ended in live birth.
EpidemiologicalDaniel Swarr
In the Cincinnati cohort, cesarean section rate was 49%, preterm labor was 14%, delivery for maternal indications was 16.7%, and delivery for fetal well-being was 16.7%.
EpidemiologicalDaniel Swarr
In the Cincinnati study, 81% of diagnoses were made prenatally, most confirmed by amniocentesis, though a few by CVS.
EpidemiologicalDaniel Swarr
Cell-free fetal DNA was performed in 50 Cincinnati pregnancies and reported as high risk in 92%, but 4 of 50 had low-risk results despite confirmed trisomy 13 or 18 diagnosis (all false negatives were trisomy 18).
EpidemiologicalDaniel Swarr
In the Cincinnati cohort, 24 cases had postnatal diagnosis; 12 had high-risk non-invasive testing prior to delivery, 2 had low-risk cell-free fetal DNA, and the remainder had declined or failed testing.
EpidemiologicalDaniel Swarr
In the Cincinnati study, median survival for trisomy 13 was 7 days with one child alive at 637 days at data collection.
EpidemiologicalDaniel Swarr
In the Cincinnati study, median survival for trisomy 18 was approximately one month with one child still alive at about 7.5 years at data collection.
EpidemiologicalDaniel Swarr
In the Cincinnati cohort, the breakdown of initial goals of care was approximately 50% choosing full intensive care as indicated, 40% comfort care, and 10% non-invasive support (high-flow nasal cannula, standard nasal cannula, or NG feeds without mechanical ventilation or surgery).
EpidemiologicalDaniel Swarr
In the Cincinnati cohort, about 25% of children across both trisomy groups received mechanical ventilation (slightly more in trisomy 13, slightly fewer in trisomy 18).
EpidemiologicalDaniel Swarr
In the Cincinnati data, of 27 infants alive at one month, approximately 50% were alive at 1 year of age.
EpidemiologicalDaniel Swarr
In the Cincinnati study, about 25% received surgical intervention (slightly more for trisomy 18, slightly less for trisomy 13), with some infants receiving multiple procedures.
EpidemiologicalDaniel Swarr
Factors associated with mortality in the Cincinnati study were trisomy 13 (vs 18), initial goals of care, extremely low birth weight, and extreme prematurity; no obvious major differences were found for common congenital anomalies.
EpidemiologicalDaniel Swarr
Fetuses and infants with trisomy 13 and 18 are at relatively high risk of intrauterine fetal demise or spontaneous loss (around 25% total in the Cincinnati study).
ClinicalDaniel Swarr
A growing body of evidence suggests that both medical and surgical interventions can increase survival rates in trisomy 13/18, though these infants have higher rates of morbidity and mortality associated with procedures.
ClinicalDaniel Swarr
Long-term survival with trisomy 13 or 18 is possible, and even with a comfort care approach, long-term survival could be a potential outcome.
ClinicalDaniel Swarr
Counseling at all stages of care should be tailored to each family and child, should be multidisciplinary and data-driven, and should adapt to multiple risk factors such as gestational age, birth weight, and complexity of surgical anomalies.
GuidelineDaniel Swarr
It is difficult to tease apart from retrospective studies whether families choosing more intensive care do so because their baby is term with fewer anomalies, or whether the interventions actually extend life.
OpinionDaniel Swarr
Prenatal diagnosis correlates with shorter survival compared to postnatal diagnosis in many retrospective studies of trisomy 13/18.
Epidemiological
The difference in survival between prenatal and postnatal diagnosis is likely related to the time families have to prepare; postnatal diagnosis families are dealing with shock and upset during the NICU period when medical decisions are being made.
OpinionDaniel Swarr